×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Image search
Paste the image URL
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Faculty of Educa... [1]
Authors
Document Type
Journal article [3]
Date Issued
2022 [2]
2021 [1]
Language
英語English [3]
Source Publication
Journal of Ethno... [1]
Research in Deve... [1]
Toxicology and A... [1]
Indexed By
SCIE [2]
SSCI [1]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-3 of 3
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Submit date Ascending
Submit date Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
Bulleyaconitine A is a sensitive substrate and competitive inhibitor of CYP3A4: One of the possible explanations for clinical adverse reactions
Journal article
Li, Xiaocui, Ou, Xiaowen, Ni, Jiadong, Xu, Yihong, Zuo, Huilin, Fu, Yu, Yang, Caihua, Zhao, Zhongxiang, Li, Na, Zhou, Hua, Zhang, Rong, Liu, Zhongqiu, Fu, Ling, Zhu, Lijun. Bulleyaconitine A is a sensitive substrate and competitive inhibitor of CYP3A4: One of the possible explanations for clinical adverse reactions[J]. Toxicology and Applied Pharmacology, 2022, 445.
Authors:
Li, Xiaocui
;
Ou, Xiaowen
;
Ni, Jiadong
;
Xu, Yihong
;
Zuo, Huilin
; et al.
Favorite
|
TC[WOS]:
2
TC[Scopus]:
2
IF:
3.3
/
3.6
|
Submit date:2023/01/30
Adverse Reaction
Bulleyaconitine a
Cytochrome P450 Enzymes
Drug-drug Interactions
Human Liver Microsomes
Metabolism
Methodology improvement for network pharmacology to correct the deviation of deduced medicinal constituents and mechanism: Xian-Ling-Gu-Bao as an example
Journal article
Li, Zheng, Qu, Biao, Wu, Xiaowen, Chen, Hongwei, Wang, Jue, Zhou, Lei, Wu, Xiaoyi, Zhang, Wei. Methodology improvement for network pharmacology to correct the deviation of deduced medicinal constituents and mechanism: Xian-Ling-Gu-Bao as an example[J]. Journal of Ethnopharmacology, 2022, 289.
Authors:
Li, Zheng
;
Qu, Biao
;
Wu, Xiaowen
;
Chen, Hongwei
;
Wang, Jue
; et al.
Favorite
|
TC[WOS]:
8
TC[Scopus]:
7
IF:
4.8
/
4.8
|
Submit date:2023/01/30
Deviation
Herbal Formula
Limitation
Methodology
Network Pharmacology
Xian-ling-gu-bao
The effects of incorporating extended conversations into video-based story retelling instruction on oral narrative skills in adolescents with intellectual disability in China
Journal article
Li, Huan, Zhou, Xiaowen, Li, Zhaojun, Wu, Hongyu, Lin, Jiaying, Li, Xiangyu. The effects of incorporating extended conversations into video-based story retelling instruction on oral narrative skills in adolescents with intellectual disability in China, The effects of incorporating extended conversations into video-based story retelling instruction on oral narrative skills in adolescents with intellectual disability in China[J]. Research in Developmental Disabilities, Research in Developmental Disabilities, 2021, 2021, 119, 119, 104116, 104116.
Authors:
Li, Huan
;
Zhou, Xiaowen
;
Li, Zhaojun
;
Wu, Hongyu
;
Lin, Jiaying
; et al.
Favorite
|
TC[WOS]:
2
TC[Scopus]:
2
IF:
2.9
/
3.2
|
Submit date:2021/12/08
Extended Conversations
Intellectual Disability
Oral Narrative
Story Grammar
Story Retelling
Visual Support
Extended Conversations
Intellectual Disability
Oral Narrative
Story Grammar
Story Retelling
Visual Support